Protalix is the key to Socialized Medicine / Obamacare
Brazil wants to own this technology in order to provide cheap biosimilars to Brazilians. Biotech drugs for 1/10 the cost. Strategically this technology should be part of any social medicine program. Buy the technology, create an expedited approval process and save billions in social medicine. Brazil knows what they're doing. Of course that will destroy the profits if Amgen, Genentech/Roche, etc. But any country that wants to effectively cut costs should look at owning this technology outright.